SR
Sambi Reddy Jonnala
About Sambi Reddy Jonnala
Data last updated:
Sambi Reddy Jonnala is a Whole-Time Director at Hetero Drugs Limited (since 2012), Director at Hindys Lab Private Limited (since 2014) and Director at Selmar Lab Private Limited (since 2018), and holds 3 more current directorships. The companies operate in Pharma, Infrastructure and Utilities and Chemicals. The 6 current companies with reported revenue have a combined latest revenue of ₹4,643 Cr; the largest is Hetero Drugs Limited at ₹3,324 Cr (FY 2025). Earlier, Sambi Reddy Jonnala was a Director at Hazelo Lab Private Limited (2015–2018) and Director at Glenys Lab Private Limited (2015) and 7 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 01 Apr 2012 | 1993 | ₹3,324 Cr (FY 2025) | Active | |
| Director | 20 Dec 2014 | 2007 | ₹858 Cr (FY 2025) | Active | |
| Director | 31 Dec 2018 | 2013 | ₹269 Cr (FY 2024) | Active | |
| Director | 07 Oct 2015 | 2006 | ₹122 Cr (FY 2023) | Active | |
| Whole-Time Director | 24 Oct 2019 | 2019 | ₹65.12 Cr (FY 2025) | Active | |
| Director | 23 Jun 2017 | 2017 | ₹5.41 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Apr 2015 | 2015 | ₹432 Cr (FY 2024) | Active | |
| Director | 13 Apr 2015 | 2015 | Strike Off | ||
| Director | 20 Sep 2012 | 2011 | ₹2,483 Cr (FY 2025) | Active | |
| Director | 07 Sep 2015 | 2015 | ₹51.66 Cr (FY 2025) | Active | |
| Director | 25 Aug 2015 | 2015 | Strike Off | ||
| Director | 25 Aug 2015 | 2015 | Strike Off | ||
| Director | 22 Jul 2020 | 2020 | Strike Off | ||
| Director | 25 Oct 2019 | 2019 | Strike Off | ||
| Director | 11 Apr 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sambi Reddy Jonnala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Adi Sesha Giri Jagarapu | 08774486 | Hetero Drugs Limited | Director |
| Bandi Vamsikrishna | 01014619 | Hetero Drugs Limited | Director |
| Gopal Reddy Annareddy | 07306495 | Hetero Drugs Limited | Director |
| Kalavathi Bandi | 00194597 | Hetero Drugs Limited | Director |
| Kaza Sai Venkata Sharath Krishna | Hetero Drugs Limited | Company Secretary | |
| Parthasaradhi Reddy Bandi | 00015899 | Hetero Drugs Limited | Director |
| Venkatanarasa Reddy Attunuri | 00023432 | Hetero Drugs Limited | Director |
| Kesireddy Subhas Chander Reddy | 07254929 | Hindys Lab Private Limited | Director |
| Rapolu Raji Reddy | 00694348 | Selmar Lab Private Limited | Additional Director |
| Mohana Reddy Chilukuri | 00208921 | Hetero Infrastructure Sez Private Limited | Director |
| Venkata Rao Yaramasu | 01046905 | Hetero Infrastructure Sez Private Limited , Vibhavari Industries Limited | Additional Director |
| Sateesh Reddy Tiyyagura | 07505272 | Valary Lab Private Limited , Vibhavari Industries Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sambi Reddy Jonnala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sambi Reddy Jonnala
Sambi Reddy Jonnala currently holds 6 directorships: Hetero Drugs Limited (Whole-Time Director, since 01 Apr 2012, revenue ₹3,324 Cr (FY 2025)); Hindys Lab Private Limited (Director, since 20 Dec 2014, revenue ₹858 Cr (FY 2025)); Selmar Lab Private Limited (Director, since 31 Dec 2018, revenue ₹269 Cr (FY 2024)); Hetero Infrastructure Sez Private Limited (Director, since 07 Oct 2015, revenue ₹122 Cr (FY 2023)); Valary Lab Private Limited (Whole-Time Director, since 24 Oct 2019, revenue ₹65.12 Cr (FY 2025)); and 1 more.
Sambi Reddy Jonnala was first appointed on 01 Apr 2012 as Whole-Time Director at Hetero Drugs Limited. The most recent appointment on record is 22 Jul 2020 at Shadri Labs Private Limited.
The 6 current companies of Sambi Reddy Jonnala that report revenue have a combined latest revenue of ₹4,643 Cr: Hetero Drugs Limited ₹3,324 Cr (FY 2025); Hindys Lab Private Limited ₹858 Cr (FY 2025); Selmar Lab Private Limited ₹269 Cr (FY 2024); Hetero Infrastructure Sez Private Limited ₹122 Cr (FY 2023); Valary Lab Private Limited ₹65.12 Cr (FY 2025); and 1 more.
Sambi Reddy Jonnala held 9 earlier board appointments: Hazelo Lab Private Limited (Director, 13 Apr 2015 to 01 Oct 2018); Glenys Lab Private Limited (Director, 13 Apr 2015 to 20 Aug 2015); Honour Lab Limited (Director, 20 Sep 2012 to 17 Jul 2015); Audree Infotech Private Limited (Director, 07 Sep 2015 to 16 Nov 2017); Hexisa Lab Private Limited (Director, from 25 Aug 2015); and 4 more.
The current boards of Sambi Reddy Jonnala's companies include Adi Sesha Giri Jagarapu (Hetero Drugs Limited), Bandi Vamsikrishna (Hetero Drugs Limited), Gopal Reddy Annareddy (Hetero Drugs Limited), Kalavathi Bandi (Hetero Drugs Limited), Kaza Sai Venkata Sharath Krishna (Hetero Drugs Limited), Parthasaradhi Reddy Bandi (Hetero Drugs Limited), among others.